FindTrial
Sign In

Bleeding in sinus endoscopy in two methods of anesthesia

Comparison of bleeding between two methods of general anesthesia: propofol-Remifentanil versus isoflurane-N2O in endoscopic sinus surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202067488N3
Enrollment
50
Registered
2012-10-14
Start date
2011-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Sinusitis. Incl.: abscess empyema infection suppuration (chronic) of sinus (accessory)(nasal)

Interventions

Intervention 1: Isofloran 1.2mac N2O. Intervention 2: Remifentanil 0.25micg/kg/min Propofol 150micg/kg /min.
Treatment - Drugs
Isofloran 1.2mac N2O
Remifentanil 0.25micg/kg/min Propofol 150micg/kg /min

Sponsors

Kerman University of Medical Sciences( research and technology center)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all patients that candidate for endoscopic sinus surgery with ASA classification 1 and 2 that signed informed consent Exclusion criteria : use of anticoagulants or anti-hypertension drugs;any contraindication for use of remifentanil and propofol or other anesthetics; history of diabetes, hypertension; renal or hepatic failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood pressur. Timepoint: per 10 min. Method of measurement: mmhg by electronic monitor.;Heart Rate. Timepoint: every 10 min. Method of measurement: ECG monitor.;Deepness of anesthesia. Timepoint: every 10 min. Method of measurement: BIS.—

Secondary

MeasureTime frame
Bleeding volume. Timepoint: End of surgery. Method of measurement: By measuring hemoglobin and volume of suction cantainer.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Haghbin

Kerman University of Medical sciences

m.a.haghbin@gmail.com+98 34 1211 5814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026